Clinical implications of DNA methylation in hepatocellular carcinoma

HPB

Volumn 13, Issue 6, 2011, Pages 369-376

  Sceusi, Eric L ^a   Loose, David S ^a   Wray, Curtis J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Epigenetics; Hepatocellular carcinoma; Methylation

Indexed keywords

DNA;

CANCER DIAGNOSIS; CANCER MODEL; CANCER RISK; CARCINOGENESIS; CLINICAL ASSESSMENT; CPG ISLAND; DNA METHYLATION; EARLY CANCER; EPIGENETICS; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PREMEDICATION; PROGNOSIS; REVIEW;

EID: 79957580468     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2011.00303.x     Document Type: Review

References (63)

1. Soreide K, Nedrebo BS, Knapp JC, Glomsaker TB, Soreide JA, Korner H. (2009) Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist. Surg Oncol 18:31-50.
2. Fearon ER, Vogelstein B. (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767.
3. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J et al. (2002) Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A 99:9433-9438.
4. Zingg JM, Jones PA. (1997) Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18:869-882.
5. Gardiner-Garden M, Frommer M. (1987) CpG islands in vertebrate genomes. J Mol Biol 196:261-282. (Pubitemid 17122132)
6. Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF et al. (2001) Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 10:1413-1419. (Pubitemid 32640670)
7. Costello JF, Plass C. (2001) Methylation matters. J Med Genet 38:285-303. (Pubitemid 32433981)
8. Nabilsi NH, Broaddus RR, Loose DS. (2009) DNA methylation inhibits p53-mediated survivin repression. Oncogene 28:2046-2050.
9. Sun L, Hui AM, Kanai Y, Sakamoto M, Hirohashi S. (1997) Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis. Jpn J Cancer Res 88:1165-1170. (Pubitemid 28048263)
10. Li E, Bestor TH, Jaenisch R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926.
11. Horii J, Hiraoka S, Kato J, Harada K, Kuwaki K, Fujita H et al. (2008) Age-related methylation in normal colon mucosa differs between the proximal and distal colon in patients who underwent colonoscopy. Clin Biochem 41:1440-1448.
12. Knudson AG. (1996) Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol 122:135-140.
13. Feinberg AP, Ohlsson R, Henikoff S. (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21-33. (Pubitemid 41828945)
14. Kopp-Schneider A, Portier C, Bannasch P. (1998) A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events. Math Biosci 148:181-204. (Pubitemid 28224431)
15. Ushijima T. (2007) Epigenetic field for cancerization. J Biochem Mol Biol 40:142-150.
16. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S. (2000) Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis - a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on eight CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 32:970-979.
17. Fellous TG, Islam S, Tadrous PJ, Elia G, Kocher HM, Bhattacharya S et al. (2009) Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology 49:1655-1663.
18. Gaudio E, Carpino G, Cardinale V, Franchitto A, Onori P, Alvaro D. (2009) New insights into liver stem cells. Dig Liver Dis 41:455-462.
19. Alison MR, Islam S, Lim S. (2009) Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 217:282-298.
20. Lorenzini S, Bird TG, Boulter L, Bellamy C, Samuel K, Aucott R et al. (2010) Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut 59:645-654.
21. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY et al. (2009) EpCAM positive hepatocellular carcinoma cells are tumor initiating cells with stem/progenitor cell features. Gastroenterology 136:1012-1024.
22. Marquardt JU, Factor VM, Thorgeirsson SS. (2010) Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. J Hepatol 53:568-577.
23. Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA et al. (2010) Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp Mol Pathol 89:27-35.
24. Lee EK, Han GY, Park HW, Song YJ, Kim CW. (2010) Transgelin promotes migration and invasion of cancer stem cells. J Proteome Res 9:5108-5117.
25. Esteller M, Corn PG, Baylin SB, Herman JG. (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229. (Pubitemid 32695003)
26. Waki T, Tamura G, Sato M, Motoyama T. (2003) Age-related methylation of tumour suppressor and tumour-related genes: an analysis of autopsy samples. Oncogene 22:4128-4133. (Pubitemid 36819653)
27. Farazi PA, DePinho RA. (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674-687. (Pubitemid 44286000)
28. Maeta Y, Shiota G, Okano J, Murawaki Y. (2005) Effect of promoter methylation of the p16 gene on phosphorylation of retinoblastoma gene product and growth of hepatocellular carcinoma cells. Tumour Biol 26:300-305. (Pubitemid 41619460)
29. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH. (2003) Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163:1371-1378. (Pubitemid 37175085)
30. Kaneto H, Sasaki S, Yamamoto H, Itoh F, Toyota M, Suzuki H et al. (2001) Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut 48:372-377. (Pubitemid 32269566)
31. Shim YH, Yoon GS, Choi HJ, Chung YH, Yu E. (2003) p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis. Cancer Lett 190:213-219. (Pubitemid 36136020)
32. Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. (2008) Aberrant methylation of multiple tumour suppressor genes in ageing liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 47: 908-918. (Pubitemid 351449682)
33. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H. (1999) p16(INK4A) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 116:394-400. (Pubitemid 29055363)
34. Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M et al. (1997) The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 71:355-359. (Pubitemid 27224296)
35. Wong IH, Lo YM, Yeo W, Lau WY, Johnson PJ. (2000) Frequent p15 promoter methylation in tumour and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res 6:3516-3521.
36. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE et al. (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28:29-35. (Pubitemid 32405812)
37. Du Y, Carling T, Fang W, Piao Z, Sheu JC, Huang S. (2001) Hypermethylation in human cancers of the RIZ1 tumour suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 61:8094-8099. (Pubitemid 33091596)
38. Archer KJ, Mas VR, Maluf DG, Fisher RA. (2010) High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Mol Genet Genomics 283:341-349.
39. Csepregi A, Rocken C, Hoffmann J, Gu P, Saliger S, Muller O et al. (2008) APC promoter methylation and protein expression in hepatocellular carcinoma. J Cancer Res Clin Oncol 134:579-589.
40. He N, Park K, Zhang Y, Huang J, Lu S, Wang L. (2008) Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth. Gastroenterology 134:793-802. (Pubitemid 351312736)
41. Arasaradnam RP, Khoo KT, Bradburn M, Mathers JC, Kelly SB. (2010) DNA methylation of ESR-1 and N-33 in colorectal mucosa of patients with ulcerative colitis (UC). Epigenetics 5:422-426.
42. Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y et al. (2009) A multicentre, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's oesophagus. Cancer Res 69:4112-4115.
43. Clement G, Guilleret I, He B, Yagui-Beltran A, Lin YC, You L et al. (2008) Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's oesophagus. Cancer Sci 99:46-53. (Pubitemid 350239030)
44. Liu H, Zhou Y, Boggs SE, Belinsky SA, Liu J. (2007) Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B. Oncogene 26:5900-5910.
45. Tang M, Xu W, Wang Q, Xiao W, Xu R. (2009) Potential of DNMT and its epigenetic regulation for lung cancer therapy. Curr Genomics 10:336-352.
46. Cheng Y, Zhang C, Zhao J, Wang C, Xu Y, Han Z et al. (2010) Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma. Exp Mol Pathol 88:112-117.
47. Sakamoto J, Fujiya M, Okamoto K, Nata T, Inaba Y, Moriichi K et al. (2010) Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer. Cancer Epidemiol 34:194-199.
48. Glockner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J et al. (2009) Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 69:4691-4699.
49. Ehrlich M. (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21:5400-5413.
50. Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A et al. (2008) Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Clin Cancer Res 14:7405-7412.
51. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G et al. (2001) Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27:31-39. (Pubitemid 32044515)
52. Zhao J, Zhang X, Shi M, Xu H, Jin J, Ni H et al. (2006) TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Hepatology 44:205-215. (Pubitemid 44049153)
53. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R et al. (2007) Activation of p53 byMEG3 non-coding RNA. J Biol Chem 282:24731-24742. (Pubitemid 47347547)
54. Zheng S, Chen P, McMillan A, Lafuente A, Lafuente MJ, Ballesta A et al. (2000) Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumours. Carcinogenesis 21:2057-2064.
55. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC et al. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1in human cancers. Nat Med 1:686-692.
56. Hernandez-Vargas H, Lambert MP, Le Calvez-Kelm F, Gouysse G, McKay-Chopin S, Tavtigian SV et al. (2010) Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS ONE 5:e9749.
57. Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S et al. (2010) Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 116:1367-1377.
58. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ et al. (2009) MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101:699-706.
59. Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H et al. (2003) Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 105:527-532. (Pubitemid 36578558)
60. Bruix J, Sherman M. (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236. (Pubitemid 43112690)
61. Huitzil-Melendez FD, Capanu M, O'Reilly EM, Duffy A, Gansukh B, Saltz LL et al. (2010) Advanced hepatocellular carcinoma: which staging systems best predict prognosis? J Clin Oncol 28:2889-2895.
62. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359:1995-2004.
63. Teodoridis JM, Hardie C, Brown R. (2008) CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett 268: 177-186.